Sign in

CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company

CURIS INC

Sign in to watch
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043505116
Phone
617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4 Conversion CDO acquired 66,667 shares (conversion)
  2. 4 Conversion CMO acquired 66,667 shares (conversion)
  3. 4 Conversion CFO acquired 66,666 shares (conversion)
  4. 4 Conversion President & CEO acquired 133,333 shares (conversion)
  5. 4 Conversion Director acquired 26,667 shares (conversion)
  6. EFFECT Other Notice of Effectiveness
  7. 8-K Event Results of operations
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 8-K Event Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. DEF 14A Proxy Proxy Statement
  16. UPLOAD Other SEC-generated Letter
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. S-3 Offering Registration Statement
  19. PRE 14A Proxy Proxy Statement (Preliminary)
  20. 8-K Event Delisting notice

Page 3 of 61 · 1,213 filings